Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Acquired Unit | Acquired



About Allergan - U.S. Dermatology Portfolio

Allergan (NYSE: AGN), fka Actavis and before that Watson Pharmaceuticals, is a global pharmaceutical company focused on developing, manufacturing, and commercializing innovative branded pharmaceuticals, high-quality generic, and over-the-counter medicines and biologic products for patients around the world. Allergan markets a portfolio of products that provide treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular, and anti-infective therapeutic categories. Actavis is also engaged in research and development. Watson Pharmaceuticals took on the name Actavis after its 2012 acquisition of the Swiss drug maker of the same name; Actavis later took on the name Allergan after its 2015 acquisition of the American health care company of the same name.

Allergan - U.S. Dermatology Portfolio Headquarters Location

Clonshaugh Business and Technology Park Coolock

Dublin, D17 E400,



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • Where is Allergan - U.S. Dermatology Portfolio's headquarters?

    Allergan - U.S. Dermatology Portfolio's headquarters is located at Clonshaugh Business and Technology Park, Dublin.

  • What is Allergan - U.S. Dermatology Portfolio's latest funding round?

    Allergan - U.S. Dermatology Portfolio's latest funding round is Acquired Unit.

  • Who are the investors of Allergan - U.S. Dermatology Portfolio?

    Investors of Allergan - U.S. Dermatology Portfolio include Almirall.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.